simendan has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banister, RE; Bayer, E; De Witt, BJ; Fields, AM; Ibrahim, IN; Kaye, AD; Richards, TA | 1 |
1 other study(ies) available for simendan and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
An analysis of responses to levosimendan in the pulmonary vascular bed of the cat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; ATP-Binding Cassette Transporters; Blood Gas Analysis; Blood Pressure; Cardiotonic Agents; Cats; Coronary Circulation; Cyclic Nucleotide Phosphodiesterases, Type 3; Depression, Chemical; Dose-Response Relationship, Drug; Hydrazones; KATP Channels; Nitric Oxide; Phosphodiesterase Inhibitors; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Pyridazines; Simendan | 2002 |